DOLORES LOPEZ-TERRADA

Concepts (612)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatoblastoma
25
2025
178
6.230
Why?
Liver Neoplasms
35
2025
1309
5.040
Why?
Oncogene Proteins, Fusion
27
2024
197
3.490
Why?
Carcinoma, Hepatocellular
15
2025
936
2.670
Why?
Dermatofibrosarcoma
9
2018
17
2.260
Why?
Translocation, Genetic
20
2024
351
2.220
Why?
Gene Rearrangement
15
2014
326
2.210
Why?
Biomarkers, Tumor
22
2024
1439
1.930
Why?
Reverse Transcriptase Polymerase Chain Reaction
23
2015
1290
1.900
Why?
In Situ Hybridization, Fluorescence
28
2016
757
1.880
Why?
Soft Tissue Neoplasms
9
2014
130
1.860
Why?
Gene Fusion
6
2024
55
1.730
Why?
Skin Neoplasms
10
2020
796
1.320
Why?
Calmodulin-Binding Proteins
6
2014
63
1.210
Why?
Child
70
2025
24226
1.130
Why?
Immunohistochemistry
22
2017
1687
1.090
Why?
Sarcoma, Ewing
7
2013
116
1.080
Why?
beta Catenin
7
2022
205
1.010
Why?
Adenomatous Polyposis Coli
2
2018
42
0.980
Why?
RNA-Binding Proteins
8
2014
576
0.960
Why?
Transcription Factors
15
2022
2584
0.940
Why?
Humans
136
2025
123053
0.930
Why?
Laboratory Proficiency Testing
1
2024
8
0.930
Why?
Mutation
13
2022
5763
0.900
Why?
Sarcoma, Clear Cell
3
2009
20
0.880
Why?
Neoplasm Proteins
7
2019
667
0.880
Why?
High-Throughput Nucleotide Sequencing
6
2024
861
0.840
Why?
Adolescent
45
2024
19096
0.810
Why?
Child, Preschool
33
2024
13881
0.770
Why?
Liposarcoma, Myxoid
2
2011
3
0.750
Why?
Bone Neoplasms
7
2018
430
0.740
Why?
Male
75
2024
60073
0.740
Why?
Female
79
2024
65520
0.730
Why?
Neoplasm Transplantation
4
2017
369
0.720
Why?
Proto-Oncogene Proteins
7
2023
548
0.710
Why?
Sarcoma
5
2014
194
0.700
Why?
Trans-Activators
4
2015
809
0.690
Why?
Neovascularization, Pathologic
3
2017
240
0.680
Why?
Neoplasms
7
2024
2758
0.670
Why?
Carcinoma, Mucoepidermoid
2
2015
13
0.670
Why?
Oncogene Fusion
4
2017
22
0.640
Why?
Biopsy
8
2021
1235
0.630
Why?
DNA, Neoplasm
10
2020
300
0.630
Why?
Neoplasms, Second Primary
2
2017
151
0.610
Why?
Proto-Oncogene Proteins B-raf
2
2017
164
0.610
Why?
Infant
29
2024
12355
0.610
Why?
Molecular Diagnostic Techniques
3
2022
148
0.590
Why?
Fibrosarcoma
3
2012
28
0.590
Why?
Young Adult
22
2021
8835
0.590
Why?
Liver Neoplasms, Experimental
1
2017
61
0.590
Why?
MAP Kinase Signaling System
2
2019
315
0.580
Why?
Genetic Testing
5
2024
994
0.580
Why?
Fibromatosis, Aggressive
3
2012
8
0.580
Why?
Thyroid Neoplasms
2
2020
197
0.570
Why?
Adult
47
2024
29006
0.570
Why?
Chromosomes, Human, Pair 1
1
2017
139
0.560
Why?
Chromosomes, Human, Pair 6
1
2017
140
0.550
Why?
Genes, APC
2
2018
13
0.550
Why?
Chromosomes, Human, Pair 7
2
2019
73
0.550
Why?
Thrombocytosis
1
2017
34
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2021
1232
0.550
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2017
98
0.540
Why?
Cholangiocarcinoma
1
2017
107
0.540
Why?
Chromosomes, Human, Pair 12
2
2016
93
0.530
Why?
Phenotype
5
2017
4220
0.530
Why?
Repressor Proteins
5
2022
810
0.530
Why?
Liver
6
2023
1734
0.530
Why?
RNA-Binding Protein EWS
10
2014
34
0.530
Why?
Zinc Finger Protein GLI1
1
2016
37
0.520
Why?
Epithelioid Cells
3
2012
11
0.520
Why?
Gene Expression Regulation, Neoplastic
13
2022
1872
0.520
Why?
Calcium-Binding Proteins
2
2015
327
0.510
Why?
Liver Diseases
2
2019
363
0.510
Why?
Oncogenes
1
2016
168
0.510
Why?
Chromosomes, Human, Pair 17
4
2014
371
0.510
Why?
RNA-Binding Protein FUS
2
2012
13
0.500
Why?
Neuroblastoma
2
2017
513
0.500
Why?
Thyroid Nodule
1
2015
20
0.500
Why?
Hemangioendothelioma, Epithelioid
1
2015
9
0.500
Why?
Salivary Gland Neoplasms
2
2015
55
0.500
Why?
Carcinogenesis
2
2023
328
0.480
Why?
Neoplasm Recurrence, Local
8
2024
1118
0.480
Why?
Mental Retardation, X-Linked
1
2015
77
0.480
Why?
Cauda Equina
1
2014
9
0.480
Why?
Peripheral Nervous System Neoplasms
1
2014
12
0.480
Why?
Prognosis
13
2021
4513
0.480
Why?
Cyclin B
1
2014
23
0.480
Why?
Glomus Tumor
1
2014
13
0.470
Why?
WT1 Proteins
1
2014
27
0.470
Why?
Cell Line, Tumor
8
2024
3292
0.470
Why?
Proto-Oncogene Proteins c-sis
2
2012
19
0.450
Why?
Histiocytosis, Langerhans-Cell
1
2017
221
0.450
Why?
Sarcoma, Synovial
4
2021
21
0.450
Why?
Actins
1
2016
341
0.440
Why?
Intracellular Signaling Peptides and Proteins
3
2015
555
0.430
Why?
Collagen Type I
2
2012
110
0.430
Why?
Pathologists
2
2024
29
0.430
Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2013
66
0.430
Why?
Chromosomes, Human, Pair 11
4
2013
85
0.430
Why?
Lymphoma, Large-Cell, Anaplastic
3
2022
45
0.430
Why?
Carcinoma
1
2015
278
0.420
Why?
Neuroectodermal Tumors, Primitive, Peripheral
3
2008
18
0.420
Why?
Neoplastic Cells, Circulating
2
2024
70
0.420
Why?
Methyl-CpG-Binding Protein 2
1
2015
306
0.420
Why?
Hodgkin Disease
2
2015
293
0.410
Why?
Thoracic Neoplasms
1
2012
36
0.410
Why?
Receptor Protein-Tyrosine Kinases
3
2022
133
0.410
Why?
Leukemia, Myeloid, Acute
2
2017
532
0.410
Why?
DNA-Binding Proteins
4
2011
2053
0.410
Why?
Thoracic Vertebrae
1
2012
66
0.410
Why?
Myeloproliferative Disorders
2
2013
90
0.400
Why?
Rhabdomyosarcoma, Alveolar
2
2009
37
0.400
Why?
Isochromosomes
1
2012
18
0.400
Why?
Spinal Neoplasms
1
2012
59
0.400
Why?
Cell Differentiation
4
2021
1909
0.400
Why?
Chromosome Aberrations
6
2020
614
0.390
Why?
Parotid Gland
1
2011
20
0.390
Why?
Middle Aged
34
2024
25987
0.390
Why?
Chromosomes, Human, Pair 8
2
2024
78
0.390
Why?
Vulvar Neoplasms
2
2008
18
0.380
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
139
0.380
Why?
Stem Cells
1
2016
700
0.380
Why?
Xenograft Model Antitumor Assays
5
2024
887
0.380
Why?
Cell Dedifferentiation
1
2010
21
0.360
Why?
Liposarcoma
1
2010
21
0.360
Why?
Drug Screening Assays, Antitumor
1
2010
94
0.360
Why?
Simian virus 40
3
2008
197
0.360
Why?
DNA Primers
2
2010
660
0.350
Why?
Stomach Neoplasms
2
2016
538
0.350
Why?
Chromosome Breakpoints
1
2010
80
0.350
Why?
Histiocytoma, Benign Fibrous
1
2010
12
0.350
Why?
Tumor Virus Infections
2
2008
134
0.350
Why?
Polyomavirus Infections
2
2008
90
0.350
Why?
Chimera
1
2010
87
0.340
Why?
Sequence Analysis, RNA
2
2024
375
0.340
Why?
Neoplasm Invasiveness
4
2017
604
0.340
Why?
SMARCB1 Protein
2
2020
35
0.330
Why?
Receptors, Cell Surface
1
2011
468
0.330
Why?
DNA Mutational Analysis
6
2015
790
0.330
Why?
Treatment Outcome
13
2023
12119
0.330
Why?
Pathology
1
2009
39
0.330
Why?
Aged
21
2024
19088
0.330
Why?
CREB-Binding Protein
1
2009
63
0.320
Why?
Cell Transformation, Neoplastic
2
2011
617
0.320
Why?
Heterografts
3
2024
179
0.320
Why?
Antigens, CD34
4
2012
108
0.320
Why?
Palatine Tonsil
2
2008
36
0.320
Why?
Mice
14
2024
17534
0.320
Why?
Cerebellar Neoplasms
1
2012
282
0.320
Why?
Wnt Proteins
2
2009
196
0.310
Why?
Neoplasm Staging
6
2021
1213
0.310
Why?
Medulloblastoma
1
2012
338
0.310
Why?
Chondrosarcoma
1
2008
10
0.310
Why?
Pharyngeal Diseases
1
2008
17
0.310
Why?
Genomics
5
2024
1475
0.300
Why?
Glioma
2
2022
496
0.290
Why?
Myofibroma
2
2017
9
0.280
Why?
Fasciitis
2
2017
20
0.280
Why?
Algorithms
2
2022
1592
0.270
Why?
Tumor Suppressor Protein p53
5
2019
715
0.270
Why?
Real-Time Polymerase Chain Reaction
4
2016
510
0.270
Why?
Combined Modality Therapy
5
2021
1237
0.270
Why?
Immunophenotyping
3
2017
328
0.260
Why?
Sarcoma, Alveolar Soft Part
3
2012
10
0.260
Why?
Sequence Analysis, DNA
6
2022
1751
0.260
Why?
Animals
16
2024
33785
0.250
Why?
Intestinal Neoplasms
1
2006
39
0.250
Why?
Infant, Newborn
11
2021
8109
0.250
Why?
Tumor Burden
2
2017
230
0.250
Why?
Karyotyping
6
2016
330
0.250
Why?
Diagnosis, Differential
7
2024
1876
0.240
Why?
Genetic Predisposition to Disease
5
2016
3074
0.240
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
4
2015
175
0.240
Why?
Fatal Outcome
5
2017
355
0.240
Why?
Germ-Line Mutation
3
2018
313
0.240
Why?
Base Sequence
9
2012
3092
0.240
Why?
Carcinoma, Renal Cell
2
2020
240
0.240
Why?
Databases, Factual
3
2020
1171
0.230
Why?
Proto-Oncogene Proteins c-bcl-2
2
2024
171
0.230
Why?
Glypicans
1
2024
39
0.230
Why?
Histiocytes
2
2017
23
0.230
Why?
Molecular Sequence Data
9
2012
3868
0.230
Why?
Risk Factors
8
2021
10012
0.230
Why?
Interleukin-15
1
2024
91
0.230
Why?
Chromosomes, Human, Pair 22
6
2013
102
0.220
Why?
Molecular Biology
2
2011
77
0.220
Why?
Indocyanine Green
1
2024
58
0.220
Why?
Tertiary Care Centers
1
2024
235
0.220
Why?
Sensitivity and Specificity
2
2024
2014
0.220
Why?
Mice, SCID
2
2017
570
0.210
Why?
Disease-Free Survival
5
2020
859
0.210
Why?
Leukemia, Megakaryoblastic, Acute
1
2022
20
0.210
Why?
Sclerosis
2
2012
32
0.200
Why?
Burkitt Lymphoma
1
2024
146
0.200
Why?
Cytogenetic Analysis
3
2014
79
0.200
Why?
alpha-Fetoproteins
3
2023
131
0.200
Why?
Neoplasm Grading
2
2014
268
0.200
Why?
Antigens, Polyomavirus Transforming
3
2008
87
0.200
Why?
Neutrophils
2
2001
373
0.200
Why?
Yttrium Radioisotopes
1
2021
18
0.190
Why?
Retrospective Studies
11
2023
16036
0.190
Why?
Ki-67 Antigen
3
2024
113
0.190
Why?
Skull Neoplasms
1
2001
14
0.190
Why?
Ki-1 Antigen
1
2001
27
0.190
Why?
Lymphatic Metastasis
3
2020
400
0.190
Why?
Tumor Cells, Cultured
5
2020
1061
0.190
Why?
Osteosarcoma
3
2003
257
0.180
Why?
Fixatives
2
2012
14
0.180
Why?
Disease Models, Animal
4
2023
4284
0.180
Why?
Paraffin Embedding
2
2012
30
0.180
Why?
Formaldehyde
2
2012
31
0.180
Why?
Inpatients
1
2024
464
0.180
Why?
Epstein-Barr Virus Infections
2
2022
289
0.180
Why?
Ubiquitin Thiolesterase
2
2017
56
0.180
Why?
Carcinoma, Medullary
1
2020
15
0.180
Why?
Hospitals
1
2023
392
0.170
Why?
Bone Marrow
3
2017
324
0.170
Why?
Hemangioma, Capillary
1
2020
17
0.170
Why?
Cell Cycle Proteins
3
2023
643
0.170
Why?
Carcinoma, Papillary
1
2020
77
0.170
Why?
Craniocerebral Trauma
1
2001
136
0.170
Why?
Ependymoma
1
2021
134
0.170
Why?
Sarcoma, Myeloid
1
2019
12
0.170
Why?
Proton Therapy
1
2021
123
0.170
Why?
Leukocytosis
2
2017
42
0.170
Why?
Hospitals, Pediatric
1
2024
780
0.170
Why?
DNA Copy Number Variations
2
2022
940
0.170
Why?
Neoadjuvant Therapy
1
2021
321
0.170
Why?
Precursor Cells, B-Lymphoid
1
2019
13
0.170
Why?
Central Nervous System Neoplasms
1
2022
194
0.170
Why?
Leukemia, Myelomonocytic, Juvenile
1
2019
9
0.170
Why?
Azacitidine
1
2019
54
0.160
Why?
Tracheal Neoplasms
1
1999
21
0.160
Why?
Neuroectodermal Tumors, Primitive
2
1998
52
0.160
Why?
Neuroectodermal Tumors
1
1999
11
0.160
Why?
Lymph Nodes
3
2017
376
0.160
Why?
Embolization, Therapeutic
1
2021
227
0.160
Why?
Hemangioma
1
2020
95
0.160
Why?
Serine Endopeptidases
2
2018
175
0.160
Why?
Discoidin Domain Receptor 2
1
2018
5
0.160
Why?
Survival Rate
4
2021
1997
0.160
Why?
Adamantinoma
1
2018
2
0.160
Why?
Rhabdoid Tumor
1
2019
49
0.160
Why?
Proteostasis
1
2019
34
0.150
Why?
Postoperative Hemorrhage
1
2019
86
0.150
Why?
Carcinoma, Small Cell
1
2018
50
0.150
Why?
Non-alcoholic Fatty Liver Disease
1
2023
389
0.150
Why?
Gene Amplification
2
2013
228
0.150
Why?
Endoplasmic Reticulum Stress
1
2019
120
0.150
Why?
DNA Replication
1
2020
349
0.150
Why?
Biopsy, Fine-Needle
4
2013
115
0.150
Why?
Antimetabolites, Antineoplastic
1
2019
178
0.150
Why?
Cooperative Behavior
2
2016
216
0.150
Why?
Promoter Regions, Genetic
3
2017
1338
0.150
Why?
Hep G2 Cells
1
2017
88
0.150
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2015
805
0.150
Why?
Chromosome Banding
1
2017
139
0.150
Why?
Follow-Up Studies
5
2021
5047
0.140
Why?
Forkhead Transcription Factors
3
2009
367
0.140
Why?
Mice, Inbred NOD
1
2017
285
0.140
Why?
Xanthogranuloma, Juvenile
1
2017
31
0.140
Why?
Microtubule-Associated Proteins
1
2018
244
0.140
Why?
Cell Nucleus
3
2012
674
0.140
Why?
Mitogen-Activated Protein Kinase 1
1
2017
111
0.140
Why?
Sarcoma, Small Cell
1
1996
1
0.140
Why?
Cytogenetics
1
1996
16
0.140
Why?
Monosomy
1
1996
24
0.140
Why?
Liver Transplantation
3
2021
1015
0.140
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2016
49
0.140
Why?
Tissue Array Analysis
4
2009
134
0.130
Why?
Neoplasms, Glandular and Epithelial
1
2016
35
0.130
Why?
Myelodysplastic Syndromes
1
2017
137
0.130
Why?
Cohort Studies
5
2024
4702
0.130
Why?
T-Lymphocytes
1
2024
1691
0.130
Why?
Receptors, Purinergic P2X3
1
2015
3
0.130
Why?
Chromosome Mapping
3
2023
1081
0.130
Why?
Transcriptional Regulator ERG
2
2013
40
0.130
Why?
Nose Neoplasms
1
1996
31
0.130
Why?
Proto-Oncogene Proteins c-ret
1
2015
29
0.130
Why?
NF-E2-Related Factor 2
1
2016
102
0.130
Why?
Transplantation Conditioning
1
2017
323
0.130
Why?
Kidney Neoplasms
1
2020
432
0.130
Why?
Autophagy
1
2019
390
0.130
Why?
Genes, Tumor Suppressor
1
2016
202
0.130
Why?
Interleukin-8
1
2016
209
0.130
Why?
Ikaros Transcription Factor
1
2015
28
0.130
Why?
Integrases
1
2016
161
0.120
Why?
Vinblastine
1
2015
46
0.120
Why?
Mutagenesis
1
2016
347
0.120
Why?
Ifosfamide
1
2015
39
0.120
Why?
Herpesvirus 4, Human
4
2022
663
0.120
Why?
Boronic Acids
1
2015
48
0.120
Why?
International Cooperation
1
2015
157
0.120
Why?
Bortezomib
1
2015
73
0.120
Why?
Mitotic Index
1
2014
19
0.120
Why?
Adaptor Proteins, Signal Transducing
2
2015
528
0.120
Why?
Recombination, Genetic
1
2016
446
0.120
Why?
Pyrazines
1
2015
73
0.120
Why?
Telomerase
1
2015
161
0.120
Why?
Ovarian Neoplasms
1
2018
408
0.120
Why?
Neoplasms, Multiple Primary
3
2012
73
0.120
Why?
Diagnostic Errors
1
2018
327
0.120
Why?
Risk
1
2016
745
0.110
Why?
Mice, Knockout
3
2019
3718
0.110
Why?
Myeloid Cells
1
2014
98
0.110
Why?
Leukemia, Promyelocytic, Acute
1
2014
24
0.110
Why?
Neoplasm Metastasis
2
2020
653
0.110
Why?
Muir-Torre Syndrome
1
2013
1
0.110
Why?
Polymerase Chain Reaction
5
2008
1584
0.110
Why?
Laparoscopy
1
2019
501
0.110
Why?
Long Interspersed Nucleotide Elements
1
2013
35
0.110
Why?
Time Factors
5
2021
6222
0.110
Why?
Phosphoproteins
1
2015
399
0.110
Why?
Lipoma
1
2013
23
0.110
Why?
Retroperitoneal Neoplasms
1
2013
31
0.110
Why?
Lymphoma, AIDS-Related
2
2005
37
0.110
Why?
Chromosomal Instability
1
2013
58
0.110
Why?
Estrogen Receptor alpha
1
2016
454
0.100
Why?
Fibroma
1
2013
30
0.100
Why?
Multiplex Polymerase Chain Reaction
1
2012
29
0.100
Why?
Brain Neoplasms
1
2022
1236
0.100
Why?
Mucin-4
1
2012
11
0.100
Why?
Cells, Cultured
3
2017
3042
0.100
Why?
Lymphocytes
1
2014
402
0.100
Why?
Cell Lineage
1
2014
340
0.100
Why?
Microsatellite Repeats
1
2013
219
0.100
Why?
Exons
2
2012
794
0.100
Why?
Forkhead Box Protein O1
2
2009
95
0.100
Why?
Mass Screening
1
2018
785
0.100
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2013
85
0.100
Why?
Atrophy
1
2012
226
0.100
Why?
Adenocarcinoma
1
1999
993
0.100
Why?
Magnetic Resonance Imaging
2
2014
3544
0.100
Why?
Patched Receptors
1
2011
26
0.100
Why?
Age Factors
2
2015
2802
0.100
Why?
Patched-1 Receptor
1
2011
33
0.100
Why?
Tissue Fixation
1
2012
35
0.100
Why?
Genes, Neoplasm
1
2012
80
0.100
Why?
Fibromatosis, Abdominal
1
2011
1
0.100
Why?
Cross Reactions
1
2012
192
0.100
Why?
Mouth Neoplasms
1
2012
82
0.100
Why?
Hepatectomy
2
2023
109
0.100
Why?
Cell Proliferation
4
2024
2307
0.100
Why?
Alleles
1
2016
1603
0.100
Why?
Primary Myelofibrosis
1
2012
50
0.100
Why?
Proto-Oncogene Protein c-fli-1
3
2008
14
0.090
Why?
Rabbits
1
2012
709
0.090
Why?
Cysts
1
2012
100
0.090
Why?
Hematopoietic Stem Cell Transplantation
2
2017
1200
0.090
Why?
Models, Biological
1
2016
1443
0.090
Why?
Severe Combined Immunodeficiency
1
2011
105
0.090
Why?
Nuclear Envelope
1
2011
17
0.090
Why?
Europe
1
2012
350
0.090
Why?
Abdominal Neoplasms
1
2011
33
0.090
Why?
Lung Neoplasms
1
2020
1591
0.090
Why?
Ultrasonography
1
2015
940
0.090
Why?
Enzyme Induction
1
2010
103
0.090
Why?
Neoplasm, Residual
2
2009
121
0.090
Why?
Myofibroblasts
1
2011
75
0.090
Why?
Signal Transduction
4
2019
4490
0.090
Why?
Transcriptome
1
2016
902
0.090
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
79
0.090
Why?
Predictive Value of Tests
1
2015
2109
0.090
Why?
Protein-Tyrosine Kinases
1
2011
211
0.080
Why?
Transcription Factor HES-1
1
2009
16
0.080
Why?
Hepatocyte Nuclear Factor 4
1
2009
19
0.080
Why?
Insulin-Like Growth Factor II
1
2009
41
0.080
Why?
Myogenin
1
2008
10
0.080
Why?
Periodic Acid-Schiff Reaction
1
2008
3
0.080
Why?
Severity of Illness Index
1
2017
2846
0.080
Why?
Glycogen
1
2008
63
0.080
Why?
Mice, Nude
3
2020
694
0.080
Why?
Immunocompetence
1
2008
33
0.080
Why?
Proto-Oncogene Proteins c-myc
2
2020
186
0.080
Why?
Piperazines
1
2010
230
0.080
Why?
Molecular Targeted Therapy
1
2010
353
0.080
Why?
Chromosomes, Human, Pair 9
1
2008
106
0.070
Why?
Rhabdomyosarcoma, Embryonal
1
2008
51
0.070
Why?
Extremities
1
2008
83
0.070
Why?
Remission Induction
2
2019
299
0.070
Why?
Membrane Proteins
2
2020
1521
0.070
Why?
Antineoplastic Agents
3
2019
1660
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
281
0.070
Why?
ErbB Receptors
1
2009
284
0.070
Why?
Histological Techniques
1
2007
21
0.070
Why?
Neoplastic Stem Cells
1
2009
294
0.070
Why?
Lymphoma, Non-Hodgkin
2
2005
162
0.070
Why?
Skin
1
2010
506
0.070
Why?
Pyrimidines
1
2010
373
0.070
Why?
DNA Methylation
1
2013
983
0.070
Why?
Syndrome
1
2009
1115
0.070
Why?
Genome, Human
2
2024
1264
0.070
Why?
Uterine Neoplasms
1
2008
117
0.070
Why?
Antibodies, Monoclonal
1
2012
1008
0.070
Why?
Pediatrics
3
2024
1141
0.070
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2009
381
0.070
Why?
Lymphoproliferative Disorders
2
1998
224
0.070
Why?
Immunoglobulin lambda-Chains
1
2006
11
0.070
Why?
Disease Progression
3
2021
2023
0.070
Why?
Poliovirus Vaccine, Inactivated
1
2005
12
0.060
Why?
Survival Analysis
3
2016
1472
0.060
Why?
Immunoglobulin kappa-Chains
1
2006
31
0.060
Why?
Genotype
1
2012
2533
0.060
Why?
Hashimoto Disease
1
2006
21
0.060
Why?
Homeodomain Proteins
1
2009
544
0.060
Why?
Hematopoietic Stem Cells
1
2009
534
0.060
Why?
Ribonucleoproteins
2
1996
62
0.060
Why?
Nuclear Proteins
3
2018
1265
0.060
Why?
Aged, 80 and over
3
2011
6369
0.060
Why?
Age of Onset
2
2020
581
0.060
Why?
Chromosomes, Human, Pair 21
2
1996
40
0.060
Why?
Reproducibility of Results
1
2011
2825
0.060
Why?
Prospective Studies
3
2021
6027
0.060
Why?
Apoptosis
2
2022
1781
0.060
Why?
Liquid Biopsy
1
2024
12
0.060
Why?
Melanoma
2
2006
824
0.060
Why?
Pathology, Molecular
1
2024
58
0.060
Why?
Breast Neoplasms
1
2016
2479
0.060
Why?
Lymphoma
2
2005
324
0.060
Why?
Coloring Agents
1
2024
77
0.060
Why?
Fibrous Dysplasia of Bone
1
2003
7
0.060
Why?
Risk Assessment
3
2021
3316
0.060
Why?
Fibrous Dysplasia, Polyostotic
1
2003
9
0.060
Why?
Myxoma
1
2003
28
0.060
Why?
Chromosomes, Human, Pair 14
1
2024
100
0.050
Why?
Inflammation
1
2011
1401
0.050
Why?
Prevalence
1
2010
2404
0.050
Why?
Anemia, Iron-Deficiency
1
2006
133
0.050
Why?
Carcinogens
1
2023
153
0.050
Why?
Margins of Excision
1
2023
51
0.050
Why?
Cell Adhesion Molecules, Neuronal
1
2003
78
0.050
Why?
Whole Genome Sequencing
1
2024
281
0.050
Why?
B-Lymphocytes
1
2006
518
0.050
Why?
HSP40 Heat-Shock Proteins
1
2022
21
0.050
Why?
Extracellular Matrix Proteins
1
2003
147
0.050
Why?
Historiography
1
2002
2
0.050
Why?
State Medicine
1
2002
12
0.050
Why?
World Health Organization
1
2022
100
0.050
Why?
E2F6 Transcription Factor
1
2001
1
0.050
Why?
Activin Receptors
1
2001
15
0.050
Why?
Fourth Ventricle
1
2021
10
0.050
Why?
Biomarkers
1
2010
2942
0.050
Why?
B7-H1 Antigen
1
2022
110
0.050
Why?
Programmed Cell Death 1 Receptor
1
2022
113
0.050
Why?
Kaplan-Meier Estimate
3
2008
1004
0.050
Why?
Clinical Laboratory Techniques
1
2022
141
0.050
Why?
Ligands
1
2022
530
0.050
Why?
Cell Line
2
2016
2769
0.050
Why?
Brain Stem
1
2021
115
0.040
Why?
Nucleotidyltransferases
1
2020
45
0.040
Why?
Cell Cycle
2
2015
614
0.040
Why?
Cerebral Cortex
1
2003
447
0.040
Why?
Exome
1
2024
1038
0.040
Why?
Nerve Tissue Proteins
2
2003
1112
0.040
Why?
Transplantation, Heterologous
2
1997
253
0.040
Why?
Frozen Sections
1
1999
25
0.040
Why?
Heterogeneous-Nuclear Ribonucleoproteins
2
1996
25
0.040
Why?
Chromatin
1
2022
554
0.040
Why?
Proteasome Inhibitors
1
2019
60
0.040
Why?
Cytokines
1
2024
1282
0.040
Why?
Mice, 129 Strain
1
2019
98
0.040
Why?
Unfolded Protein Response
1
2019
62
0.040
Why?
Hypercalcemia
1
2018
39
0.040
Why?
Receptor, ErbB-2
1
2022
502
0.040
Why?
Practice Patterns, Physicians'
1
2024
713
0.040
Why?
Granulosa Cell Tumor
1
2018
40
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
101
0.040
Why?
Immunotherapy, Adoptive
1
2024
821
0.040
Why?
Recombinant Fusion Proteins
3
1996
764
0.040
Why?
Loss of Heterozygosity
1
2018
124
0.040
Why?
Genes, Retinoblastoma
1
1997
18
0.040
Why?
Proto-Oncogenes
1
1997
37
0.040
Why?
Codon, Nonsense
1
2018
131
0.040
Why?
Recurrence
2
2014
1419
0.040
Why?
Tissue Donors
2
1998
496
0.040
Why?
DNA Helicases
1
2018
224
0.040
Why?
Genes, p53
1
1997
213
0.030
Why?
Drug Therapy
1
2017
85
0.030
Why?
International Agencies
1
2016
28
0.030
Why?
Molecular Motor Proteins
1
2016
29
0.030
Why?
Gene Expression
2
2005
1565
0.030
Why?
Myosin Heavy Chains
1
2016
77
0.030
Why?
United States
1
2012
10646
0.030
Why?
Japan
1
2016
132
0.030
Why?
Heterozygote
1
2018
672
0.030
Why?
Delivery of Health Care
1
2002
606
0.030
Why?
Chromosome Deletion
1
2019
638
0.030
Why?
Germinal Center
2
2006
38
0.030
Why?
Ovary
1
2018
389
0.030
Why?
Nasal Mucosa
1
1996
65
0.030
Why?
Bone Marrow Transplantation
1
1998
578
0.030
Why?
Stem Cell Transplantation
1
2017
238
0.030
Why?
Wnt Signaling Pathway
1
2016
195
0.030
Why?
Up-Regulation
2
2009
862
0.030
Why?
Antineoplastic Agents, Hormonal
1
2016
254
0.030
Why?
Proportional Hazards Models
2
2008
1305
0.030
Why?
Tamoxifen
1
2016
363
0.030
Why?
Adenosine Triphosphate
1
2015
287
0.030
Why?
Surveys and Questionnaires
1
2024
3665
0.030
Why?
RNA, Small Interfering
1
2016
664
0.030
Why?
Antigens, Surface
1
2014
121
0.030
Why?
DNA, Viral
2
2005
478
0.030
Why?
Los Angeles
1
2013
17
0.030
Why?
Immediate-Early Proteins
1
1994
58
0.030
Why?
Disseminated Intravascular Coagulation
1
2014
67
0.030
Why?
Axilla
1
2013
38
0.030
Why?
MutS Homolog 2 Protein
1
2013
37
0.030
Why?
MutL Protein Homolog 1
1
2013
54
0.030
Why?
Blotting, Western
1
2015
1100
0.030
Why?
S100 Proteins
1
2013
45
0.030
Why?
Sequence Deletion
1
2015
527
0.030
Why?
Neurons
1
2003
1935
0.030
Why?
Chromosomes, Human, Pair 15
1
2014
159
0.030
Why?
Incidence
1
2020
3043
0.030
Why?
Gene Expression Profiling
2
2010
1678
0.030
Why?
Anemia, Myelophthisic
1
2012
2
0.030
Why?
Bone Marrow Examination
1
2012
14
0.030
Why?
Reticulin
1
2012
8
0.030
Why?
Drug Resistance, Neoplasm
1
2016
714
0.020
Why?
Clone Cells
2
2006
163
0.020
Why?
DNA Repair-Deficiency Disorders
1
2011
4
0.020
Why?
Remission, Spontaneous
1
2012
68
0.020
Why?
Receptors, Thrombopoietin
1
2012
31
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2015
1012
0.020
Why?
RNA, Messenger
3
2007
2809
0.020
Why?
Splenomegaly
1
2012
34
0.020
Why?
Hepatitis C
1
2015
364
0.020
Why?
Adenosine Deaminase
1
2011
74
0.020
Why?
Staining and Labeling
1
2012
183
0.020
Why?
Antigens, CD
1
2013
421
0.020
Why?
Janus Kinase 2
1
2012
136
0.020
Why?
Collagen
1
2012
316
0.020
Why?
Eosinophilia
1
2012
101
0.020
Why?
Early Termination of Clinical Trials
1
2010
15
0.020
Why?
Imatinib Mesylate
1
2010
44
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
70
0.020
Why?
Adipose Tissue
1
2013
464
0.020
Why?
Mice, Inbred C57BL
1
2019
4351
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2011
256
0.020
Why?
Benzamides
1
2010
106
0.020
Why?
Terminology as Topic
1
2011
229
0.020
Why?
PAX7 Transcription Factor
1
2008
17
0.020
Why?
MyoD Protein
1
2008
21
0.020
Why?
Hyaluronan Receptors
1
2008
66
0.020
Why?
Epigenesis, Genetic
1
2013
664
0.020
Why?
Case-Control Studies
2
2005
3239
0.020
Why?
Early Detection of Cancer
1
2011
349
0.020
Why?
Drug Administration Schedule
1
2010
724
0.020
Why?
Vulva
1
2008
18
0.020
Why?
Mutation, Missense
1
2012
845
0.020
Why?
Receptors, Notch
1
2009
202
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2007
82
0.020
Why?
Regression Analysis
1
2008
767
0.020
Why?
Gene Expression Regulation
1
1995
2524
0.020
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2006
4
0.020
Why?
Protein Kinase C
1
2007
150
0.020
Why?
Costa Rica
1
2005
10
0.020
Why?
Neprilysin
1
2006
19
0.020
Why?
Pseudolymphoma
1
2005
4
0.020
Why?
HIV Seronegativity
1
2005
26
0.020
Why?
Drug Contamination
1
2005
36
0.020
Why?
Genes, Viral
1
2005
183
0.020
Why?
Thyroid Gland
1
2006
112
0.020
Why?
Postoperative Complications
2
2012
3015
0.010
Why?
Lymphoma, B-Cell
1
2005
137
0.010
Why?
LDL-Receptor Related Proteins
1
2003
9
0.010
Why?
Receptors, Lipoprotein
1
2003
11
0.010
Why?
Mice, Neurologic Mutants
1
2003
74
0.010
Why?
Flow Cytometry
1
2006
803
0.010
Why?
Trisomy
1
2003
103
0.010
Why?
Nucleic Acid Hybridization
1
2003
396
0.010
Why?
Receptors, LDL
1
2003
88
0.010
Why?
History, 16th Century
1
2002
27
0.010
Why?
History, 17th Century
1
2002
34
0.010
Why?
Spain
1
2002
53
0.010
Why?
History, 18th Century
1
2002
69
0.010
Why?
HIV-1
1
2005
463
0.010
Why?
Comorbidity
1
2005
1495
0.010
Why?
Scalp
1
2000
56
0.010
Why?
Prednisone
1
2000
274
0.010
Why?
Vincristine
1
2000
196
0.010
Why?
Fetus
1
2003
578
0.010
Why?
Doxorubicin
1
2000
299
0.010
Why?
Transcription, Genetic
2
1995
1702
0.010
Why?
Y Chromosome
1
1998
47
0.010
Why?
Cyclophosphamide
1
2000
422
0.010
Why?
Phosphopyruvate Hydratase
1
1998
29
0.010
Why?
Viral Matrix Proteins
1
1998
109
0.010
Why?
Forearm
1
1998
44
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1997
70
0.010
Why?
Immunoenzyme Techniques
1
1998
260
0.010
Why?
Sex Chromosomes
1
1997
34
0.010
Why?
X Chromosome
1
1998
337
0.010
Why?
Fragile X Mental Retardation Protein
1
1998
125
0.010
Why?
Liver Failure
1
1997
89
0.010
Why?
In Situ Hybridization
1
1997
473
0.010
Why?
Kidney
1
2003
1335
0.010
Why?
RNA, Viral
1
1998
540
0.010
Why?
Activating Transcription Factor 1
1
1995
4
0.010
Why?
Transplantation, Homologous
1
1997
659
0.010
Why?
Mice, Inbred BALB C
1
1997
1002
0.010
Why?
Oligodeoxyribonucleotides
1
1995
135
0.010
Why?
Retroviridae Proteins, Oncogenic
1
1994
11
0.010
Why?
Precipitin Tests
1
1994
151
0.010
Why?
Reoperation
1
1997
819
0.010
Why?
Early Growth Response Protein 1
1
1994
38
0.010
Why?
In Vitro Techniques
1
1995
966
0.010
Why?
Chromosome Disorders
1
1995
309
0.010
Why?
Cloning, Molecular
1
1994
892
0.010
Why?
Recombinant Proteins
1
1995
1386
0.010
Why?
Amino Acid Sequence
1
1994
2696
0.010
Why?
HIV Infections
1
2000
1855
0.000
Why?
LOPEZ-TERRADA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (612)
Explore
_
Co-Authors (108)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_